|
| |
| | | 67427 | | 03.04.2020 | | Samsung Bioepis CH GmbH | | | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Imraldi 40 mg/0.8 ml | Injektionslösung in einer Fertigspritze | Injection solution in prefilled syringe (Adalimumab 40mg / 0.8ml) | L04AB04 | CI | | 02 | Imraldi 40 mg/0.4 ml | Injektionslösung in einer Fertigspritze | Injection solution in prefilled syringe (Adalimumab 40mg / 0.4ml) | L04AB04 | |
|
|
|
